Fortune | 财富中文网

Anta Group management reshuffle

On January 18, Beijing time, Anta Sports Products Co., Ltd. announced on the Hong Kong Stock Exchange that Ding Shizhong will step down as CEO and remain as chairman of the board of directors; Lai Shixian, chief financial officer of the group, and Wu Yonghua, CEO of professional sports brand group, will become the new

Anta Group management reshuffle Read More »

Hong Kong revoked the isolation order for confirmed cases from January 30, and the new crown will be regarded as upper respiratory disease management

According to the website of Radio Television Hong Kong and the Hong Kong Economic Daily on January 19, the Chief Executive of the Hong Kong Special Administrative Region, Li Jiachao, announced that the quarantine order for infected persons will be revoked from January 30, and the new crown virus will be listed as an upper

Hong Kong revoked the isolation order for confirmed cases from January 30, and the new crown will be regarded as upper respiratory disease management Read More »

Goldman Sachs employees receive invitations to ‘meetings’ that turn out to be layoffs

On Jan. 11, Goldman Sachs cut 3,200 jobs, or about 6.5% of its workforce. Goldman Sachs CEO Dewei Solomon. PHOTO CREDIT: PATRICK T. FALLON—BLOOMBERG VIA GETTY IMAGES It’s one thing to be laid off by a well-known investment bank like Goldman Sachs, but it’s quite another to be laid off suddenly after what you thought

Goldman Sachs employees receive invitations to ‘meetings’ that turn out to be layoffs Read More »

Member of the CPPCC: Encouraging childbearing must first solve the “worries” of young people

The birth rate of newborns has declined, and the discussion on “why this generation of young people is unwilling to give birth” has never stopped. Li Haili, a member of the Beijing Municipal People’s Political Consultative Conference and a member of the Standing Committee of the Beijing Municipal Committee of the Democratic National Construction Association,

Member of the CPPCC: Encouraging childbearing must first solve the “worries” of young people Read More »

Azivudine tablets were successfully included in the medical insurance through negotiation at 11.58 yuan

On January 18, according to the press conference on the adjustment of the 2022 National Medical Insurance Drug List, this medical insurance negotiation fully supports the treatment of new coronavirus infection. For the third consecutive year, new crown treatment drugs have been included as a condition for admission to the national medical insurance catalog. Two

Azivudine tablets were successfully included in the medical insurance through negotiation at 11.58 yuan Read More »